There are 302 resources available
Introduction to the ESMO I-O 2024 Awardee
Presenter: Aurélien Marabelle
Session: Opening session: Welcome and Award Keynote address
Resources:
Slides
Webcast
Randomised versus real-world evidence on the efficacy and toxicity of checkpoint inhibitors
Presenter: Timothée Olivier
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Immunogenicity and TCR identification in cancer immunotherapy
Presenter: Sine Reker Hadrup
Session: Computational cancer immunology
Resources:
Slides
Webcast
Prediction of immune checkpoint inhibitor outcome and side effects by use of machine learning and routine real-world data
Presenter: Travis Osterman
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Deciphering the role of TLS in cancer and immunotherapy response
Presenter: Michiel van der Heijden
Session: Scientific advances in immuno-oncology in 2024: Immuno-biology focus
Resources:
Slides
Webcast
Impact of real-world data on clinical treatment guidelines for immune therapy
Presenter: Marco Donia
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Real-world data models to identify molecular biomarkers for response to immune checkpoint inhibitors
Presenter: Patrick Pauwels
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Q&A and discussion
Session: Computational cancer immunology
Resources:
Webcast
Q&A and discussion
Session: Scientific advances in immuno-oncology in 2024: Immuno-biology focus
Resources:
Webcast
Q&A and discussion
Session: Real-world benefit of immunotherapy
Resources:
Webcast